ClinConnect ClinConnect Logo
Search / Trial NCT03135886

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

Launched by COLUMBIA UNIVERSITY · Apr 26, 2017

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Hiv Hiv Testing Hepatitis C Virus Testing Opioid Use Disorder Treatment Substance Use Disorders Treatment Hepatitis C Virus Practice Coaching

ClinConnect Summary

This clinical trial, called Project I Test, is focused on improving the way opioid treatment programs (OTPs) offer HIV and Hepatitis C testing to their patients. The study will test two different methods of support, known as "practice coaching," to see which one helps more patients get tested for HIV and linked to medical care. The goal is to find out how effective these methods are in encouraging patients to receive these important tests and follow-up care, especially for those struggling with substance use disorders.

To be eligible for this trial, treatment centers must serve at least 150 unique patients each year and be willing to collect data on testing and referrals. Participants in the trial can expect to be part of a program that aims to enhance their access to HIV and Hepatitis C testing, ensuring they receive timely support if needed. This study is currently recruiting participants and is open to all genders between the ages of 65 and 74. The results from this trial could lead to better healthcare practices and improved health outcomes for individuals in opioid treatment programs.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Eligible sites must:
  • 1. See at least 150 unduplicated patients/year/site
  • 2. Be capable and willing to prospectively collect data on the number of patients who a) are offered any HIV and/or HCV tests; b) completed these tests; c) are referred to care/evaluation (and type of referral) if positive; and d) are linked to care/evaluation within 30 days of diagnosis
  • 3. Be capable and willing to provide patient demographics, testing data within demographic categories of gender and race/ethnicity (in aggregate) and data on HIV/HCV test reimbursement processes and outcomes
  • 4. Have key staff willing to consent to participate in study surveys, qualitative interviews and intervention coaching throughout the study
  • Exclusion Criteria:
  • * Sites will be excluded if:
  • 1. Over 50% of patients served in the prior 6 months were HIV or HCV tested
  • 2. They are terminated via PI decision/discretion

About Columbia University

Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Lisa Metsch, PhD

Principal Investigator

Columbia University

Daniel Feaster, PhD

Principal Investigator

University of Miami

Jemima Frimpong, PhD

Principal Investigator

New York University Abu Dhabi

Lauren Gooden, PhD

Study Director

Columbia University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials